Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Detailed Investigation On Characteristics of Japanese Patients with Chronic Phase CML Who Achieved a Durable CMR After Discontinuation of Imatinib – an Updated Result of the Keio STIM Study.

Eri Matsuki, MD, PhD, Yukako Ono, MD, Koharu Tonegawa, Masatoshi Sakurai, MD, Hiroyoshi Kunimoto, MD, Jo Ishizawa, MD, PhD, Norisato Hashimoto, MD, Takayuki Shimizu, MD, PhD, Akiko Yamane, MD, PhD, Maiko Matsushita, MD, PhD, Kenji Yokoyama, MD, PhD, Shinichiro Okamoto, MD, PhD

Blood (2012) 120 (21): 2788.

https://doi.org/10.1182/blood.V120.21.2788.2788

Published: 2012

Journal Articles

Discontinuation of Imatinib in Patients with CML and Sustained Complete Molecular Response (CMR) for Over 2 Years in the Japanese Population – An Interim Analysis of KEIO STIM Study,

Eri Matsuki, MD, PhD, Yukako Ono, MD, Masatoshi Sakurai, MD, Hiroyoshi Kunimoto, MD, Jo Ishizawa, MD, PhD, Takayuki Shimizu, MD, PhD, Akiko Yamane, MD, PhD, Maiko Matsushita, MD, PhD, Kenji Yokoyama, MD, PhD, Shinichiro Okamoto, MD, PhD

Blood (2011) 118 (21): 3765.

https://doi.org/10.1182/blood.V118.21.3765.3765

Published: 2011

Journal Articles

Effectiveness of a Novel Humanized VB22B Minibody against Human TPO Receptor Compared with Recombinant TPO and Eltrombopag Using Primary Human CD34+ Cells and Platelets.

Eri Matsuki, MD, Akiko Yamane, MD, PhD, Shinichiro Okamoto, MD, PhD, Yoshitaka Miyakawa, MD, PhD

Blood (2009) 114 (22): 4559.

https://doi.org/10.1182/blood.V114.22.4559.4559

Published: 2009

Journal Articles

Bortezomib Induces Thrombocytopenia by Inhibiting Proplatelet Formation but Not Proliferation and Endomitosis in Human Primary Megakaryocytes

Wataru Nogami, Akiko Yamane, Takanori Nakamura, Eri Matsuki, Yasuo Ikeda, Yoshitaka Miyakawa

Blood (2008) 112 (11): 87.

https://doi.org/10.1182/blood.V112.11.87.87

Published: 2008

Journal Articles

Interferon-α2b–induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes

Akiko Yamane, Takanori Nakamura, Hidenori Suzuki, Mamoru Ito, Yasuyuki Ohnishi, Yasuo Ikeda, Yoshitaka Miyakawa

Blood (2008) 112 (3): 542–550.

https://doi.org/10.1182/blood-2007-12-125906

Published: 2008

Journal Articles

A Novel, Small Non-Peptidyl Butyzamide Activates Human Thrombopoietin Receptor and Promotes Megakaryopoiesis.

Wataru Nogami, Hiroshi Yoshida, Kenzo Koizumi, Hajime Yamada, PhD, Kenji Abe, Akinori Arimura, PhD, Noriko Yamane, Koji Takahashi, Yoshikazu Tanaka, PhD, Akiko Yamane, Hiroshi Takemoto, PhD, Yasuyuki Ohnishi, PhD, Yasuo Ikeda, MD, Yoshitaka Miyakawa, MD

Blood (2007) 110 (11): 2201.

https://doi.org/10.1182/blood.V110.11.2201.2201

Published: 2007

Journal Articles

Interferon-α2b-Induced Thrombocytopenia Is Caused by Inhibition of Cytoplasmic Maturation and Platelet Production, but Not Proliferation and Endomitosis in Human Megakaryocytes.

Akiko Yamane, MD, Takanori Nakamura, Mamoru Ito, Yasuyuki Ohnishi, Yasuo Ikeda, MD, PhD, Yoshitaka Miyakawa, MD, PhD

Blood (2007) 110 (11): 2195.

https://doi.org/10.1182/blood.V110.11.2195.2195

Published: 2007

Journal Articles

Prevention of Human Interferon-alpha-Induced Thrombocytopenia by a Non-Peptidyl Human Thrombopoietin Receptor Activator, NIP-004.

Akiko Yamane, Takanori Nakamura, Mamoru Ito, Yasuyuki Ohnishi, Yasuo Ikeda, Yoshitaka Miyakawa

Blood (2006) 108 (11): 1145.

https://doi.org/10.1182/blood.V108.11.1145.1145

Published: 2006

Journal Articles

A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis

Takanori Nakamura, Yoshitaka Miyakawa, Atsushi Miyamura, Akiko Yamane, Hidenori Suzuki, Mamoru Ito, Yasuyuki Ohnishi, Norihisa Ishiwata, Yasuo Ikeda, Nobutomo Tsuruzoe

Blood (2006) 107 (11): 4300–4307.

https://doi.org/10.1182/blood-2005-11-4433

Published: 2006

Journal Articles

A Novel Non-Peptidyl Human C-Mpl Agonist, NIP-004, Stimulates Human Megakaryopoiesis and Thrombopoiesis.

Takanori Nakamura, Yoshitaka Miyakawa, Atsushi Miyamura, Akiko Yamane, Hidenori Suzuki, Katsuaki Miyaji, Mamoru Ito, Yasuyuki Ohnishi, Norihisa Ishiwata, Yasuo Ikeda, Nobutomo Tsuruzoe

Blood (2005) 106 (11): 3148.

https://doi.org/10.1182/blood.V106.11.3148.3148

Published: 2005

Journal Articles

A Structure-Function Analysis Revealed Histidine in the Transmembrane Domain of Human Thrombopoietin Receptor Is Essential for a Novel Non-Peptidyl Thromobopoietin Mimetics, NIP-004, To Induce Signaling for Cellular Proliferation.

Akiko Yamane, Atsushi Miyamura, Takanori Nakamura, Norihisa Ishiwata, Katsuaki Miyaji, Nobutomo Tsuruzoe, Yasuo Ikeda, Yoshitaka Miyakawa

Blood (2005) 106 (11): 3149.

https://doi.org/10.1182/blood.V106.11.3149.3149

Published: 2005

NARROW

Detailed Investigation On Characteristics of Japanese Patients with Chronic Phase CML Who Achieved a Durable CMR After Discontinuation of Imatinib – an Updated Result of the Keio STIM Study.

Discontinuation of Imatinib in Patients with CML and Sustained Complete Molecular Response (CMR) for Over 2 Years in the Japanese Population – An Interim Analysis of KEIO STIM Study,

Effectiveness of a Novel Humanized VB22B Minibody against Human TPO Receptor Compared with Recombinant TPO and Eltrombopag Using Primary Human CD34+ Cells and Platelets.

Bortezomib Induces Thrombocytopenia by Inhibiting Proplatelet Formation but Not Proliferation and Endomitosis in Human Primary Megakaryocytes

Interferon-α2b–induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes

A Novel, Small Non-Peptidyl Butyzamide Activates Human Thrombopoietin Receptor and Promotes Megakaryopoiesis.

Interferon-α2b-Induced Thrombocytopenia Is Caused by Inhibition of Cytoplasmic Maturation and Platelet Production, but Not Proliferation and Endomitosis in Human Megakaryocytes.

Prevention of Human Interferon-alpha-Induced Thrombocytopenia by a Non-Peptidyl Human Thrombopoietin Receptor Activator, NIP-004.

A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis

A Novel Non-Peptidyl Human C-Mpl Agonist, NIP-004, Stimulates Human Megakaryopoiesis and Thrombopoiesis.

A Structure-Function Analysis Revealed Histidine in the Transmembrane Domain of Human Thrombopoietin Receptor Is Essential for a Novel Non-Peptidyl Thromobopoietin Mimetics, NIP-004, To Induce Signaling for Cellular Proliferation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only